Search Results 781-790 of 37919 for Two-phase

1. UBX1325 for Treatment of Neovascular ARMD - Mayo Clinic

   A Phase 2, Prospective, Multicenter, Randomized, Double-Masked, Active-Controlled Study to Assess the Safety, Tolerability, and Evidence of Activity of a ...

2. A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

3. A Compassionate Use Study to Administer NurOwn® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) to Treat Amyotrophic Lateral Sclerosis (ALS) - Mayo Clinic

   Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

4. Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age (PrE0405) - Mayo Clinic

   It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma. Venetoclax ...

5. Alcohol: Does it affect blood pressure? - Mayo Clinic

   ... two hours for women and five or more drinks within two hours for men. Average drinking is up to one drink a day for women, two for men. ... Sleep tips: 6 steps to ...

6. Infection Outcomes Assessment of Absorbable Antibacterial Soft Tissue Support in Breast Reconstruction - Mayo Clinic

   Is scheduled to undergo unilateral or bilateral mastectomy (including prophylactic) with immediate two-stage post-mastectomy alloplastic prepectoral breast ...

7. Interstitial Lung Disease Clinical Trials - Mayo Clinic Research

   ... two co-primary endpoints: 1) patient-reported quality of life as assessed by ... PSSc-001 (LOTUSS) This study is a Phase 2, multinational, open-label ...

8. VE303 for Prevention of Recurrent Clostridioides Difficile Infection - Mayo Clinic

   The objectives and endpoints are identical for Stage 1 (recurrent CDI) and Stage 2 (high-risk primary CDI). Participation eligibility. Participant eligibility ...

9. A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification - Mayo Clinic

   Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

10. Study Evaluating the Safety and Effectiveness of JCARH125 in Subjects with Relapsed and/or Refractory Multiple Myeloma (EVOLVE) - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...